Asia-Pacific Cardiac AI Monitoring and Diagnostics Market: Analysis and Forecast, 2023-2032
상품코드:1421495
리서치사:BIS Research
발행일:2024년 02월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
아시아태평양 심장 AI 모니터링 및 진단 시장 규모는 2023년 2억 40만 달러를 기록했습니다.
이 시장은 2032년 21억 5,460만 달러에 달할 것으로 예상되며, 예측 기간인 2023-2032년 동안 30.20%의 CAGR을 기록할 것으로 예상됩니다. 심장 AI 모니터링 및 진단 시장의 성장은 심혈관 질환의 확산, 의료 분야의 AI에 대한 정부 지원, 심장학에 특화된 AI 연구 증가, AI 심장 장치에 대한 규제 승인 증가, AI 심장 진단 기술의 발전으로 인해 발생할 것으로 예상됩니다.
주요 시장 통계
예측 기간
2023-2032년
2023년 평가
2억 40만 달러
2032년 예측
21억 5,460만 달러
CAGR
30.2%
아시아태평양의 심장 AI 모니터링 및 진단 시장은 몇 가지 중요한 요인으로 인해 크게 성장하고 있습니다. 이 지역은 인구 고령화와 당뇨병 및 고혈압과 같은 생활습관 관련 위험요인의 유병률 증가로 인해 심혈관 질환에 대한 높은 부담에 직면해 있습니다. 이에 따라 첨단 진단 및 모니터링 도구에 대한 수요가 증가하고 있습니다. 아시아태평양 정부들은 헬스케어 분야에서 AI의 잠재력을 점점 더 인식하고 있으며, 이는 AI 기술에 대한 지원 정책과 투자로 이어지고 있습니다. 또한, 이 지역에서는 심장병학 분야의 AI를 포함한 헬스케어 기술 연구가 급증하고 있으며, 고급 진단을 보다 친숙하고 효율적으로 만들고 있습니다. 또한, AI 기반 심장 진단 기기에 대한 규제 당국의 승인 증가는 그 효과와 안전성에 대한 신뢰가 높아진 것을 반영하고 있으며, AI의 기술 발전은 심장 진단의 정확성과 정밀도를 향상시켜 이 지역의 다양하고 증가하는 의료 수요를 충족시키고 있습니다.
이 보고서는 아시아태평양의 심장 AI 모니터링 및 진단 시장을 조사하여 시장 개요와 함께 제품별, 유형별, 용도별, 최종사용자별, 국가별 동향, 시장 진입 기업 개요 등을 제공합니다.
목차
주요 요약
제1장 시장
시장 전망
제2장 업계 전망
주요 동향
기회 평가
규제 프레임워크
특허 분석
비지니스 모델
사례 연구
진행중인 임상시험
자금 조달 시나리오
최종사용자 인식
신규 진출 기업의 참여 장벽
제3장 COVID-19의 영향
제4장 지역
아시아태평양의 심장 AI 모니터링 및 진단 시장
주요 조사 결과와 기회 평가
디지털의 도입
시장 역학
시장 규모와 예측
제5장 시장 - 경쟁 벤치마킹과 기업 개요
심장 AI 모니터링 및 진단 시장 분야의 활약 기업 생태계
주요 전략과 전개
규제 및 법적 활동
기업 개요
Canon Inc.
ksm
영문 목차
영문목차
“The Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Expected to Reach $2,154.6 Million by 2032.”
Introduction to Asia-Pacific Cardiac AI Monitoring and Diagnostics Market
The Asia-Pacific cardiac AI monitoring and diagnostics market was valued at $200.4 million in 2023 and is anticipated to reach $2,154.6 million by 2032, witnessing a CAGR of 30.20% during the forecast period 2023-2032. Growth in the cardiac AI monitoring and diagnostics market is driven by widespread cardiovascular diseases, government support for AI in healthcare, increasing cardiology-focused AI research, more regulatory approvals for AI cardiac devices, and advances in AI cardiac diagnostics technology.
KEY MARKET STATISTICS
Forecast Period
2023 - 2032
2023 Evaluation
$200.4 Million
2032 Forecast
$2,154.6 Million
CAGR
30.2%
Market Introduction
The Asia-Pacific (APAC) market for cardiac AI monitoring and diagnostics is witnessing significant growth, driven by several key factors. The region faces a high burden of cardiovascular diseases, fueled by aging populations and increasing prevalence of lifestyle-related risk factors like diabetes and hypertension. This has heightened the demand for advanced diagnostic and monitoring tools. Governments across APAC are increasingly recognizing the potential of AI in healthcare, leading to supportive policies and investments in AI technology. Additionally, the region is seeing a surge in healthcare technology research, including AI applications in cardiology, making advanced diagnostics more accessible and efficient. Furthermore, the increasing number of regulatory approvals for AI-based cardiac diagnostic devices reflects a growing trust in their effectiveness and safety. Technological advancements in AI are enhancing the precision and accuracy of cardiac diagnostics, catering to the region's diverse and expanding healthcare needs.
Market Segmentation:
Segmentation 1: by Product
Software
Hardware
Segmentation 2: by Type
Cardiac Diagnostics
Imaging
ECG-Based
Others
Cardiac Monitoring
Segmentation 3: by Application
Ischemic Heart Disease/CAD
Cardiac Arrhythmias
Ischemic Stroke
Others
Segmentation 4: by End User
Hospitals
Diagnostic Centers
Other End Users
Segmentation 5: by Country
China
Japan
India
Australia
South Korea
Rest-of-Asia-Pacific
How Can This Report Add Value to an Organization?
Product/Innovation Strategy: The APAC cardiac AI monitoring and diagnostics market has been extensively segmented based on various categories, such as products, types, applications, end users, and regions. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.
Table of Contents
Executive Summary
1. Market
1.1. Market Outlook
1.1.1. Product Definition
1.1.2. Inclusion Criteria
1.1.3. Exclusion Criteria
1.1.4. Overview
1.1.4.1. Market Size and Growth Potential
2. Industry Outlook
2.1. Key Trends
2.1.1. Rising Number of Startups in the Market
2.1.2. Increased Awareness Regarding Preventative Measures and Personalized Treatment
2.1.3. Growing Demand for Wearable Sensors for Cardiac Monitoring Leading to Increased Adoption of AI-Enabled Solutions for Home-Based Care
2.2. Opportunity Assessment
2.3. Regulatory Framework
2.3.1. Regulatory Framework for Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms
2.3.2. Regulatory Framework in Japan
2.3.3. Regulatory Framework in China
2.4. Patent Analysis
2.4.1. Awaited Technological Developments
2.4.1.1. Patent Analysis (by Country)
2.4.1.2. Patent Analysis (by Year)
2.5. Business Models
2.6. Case Studies
2.6.1. Case Study 1: Ultromics Limited
2.6.1.1. The EchoGo System
2.6.1.1.1. Developement
2.6.1.1.2. Use Case and Reliability
2.6.1.2. A Success Story
2.6.1.3. Partners and Recognitions
2.6.2. Case Study 2: CorVista Health, Inc.
2.6.2.1. The CorVista System
2.6.2.2. A Success Story
2.7. Ongoing Clinical Trials
2.8. Funding Scenario
2.9. End User Perception
2.1. Entry Barriers for New Entrants
3. Impact of COVID-19
3.1. Impact on the Overall Market
3.2. Pre-COVID-19 Scenario
3.3. During COVID-19 Scenario
3.4. Post COVID-19 Scenario
4. Regions
4.1. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market
4.1.1. Key Findings and Opportunity Assessment
4.1.2. Digital Adoption
4.1.3. Market Dynamics
4.1.3.1. Impact Analysis
4.1.4. Market Sizing and Forecast
4.1.4.1. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product)
4.1.4.2. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type)
4.1.4.2.1. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
4.1.4.3. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application)
4.1.4.4. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User)
4.1.4.5. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Country)
4.1.4.5.1. Japan
4.1.4.5.1.1. Market Dynamics
4.1.4.5.1.2. Market Size and Forecast
4.1.4.5.1.2.1. Japan Cardiac AI Monitoring and Diagnostics Market (by Product)
4.1.4.5.1.2.2. Japan Cardiac AI Monitoring and Diagnostics Market (by Type)
4.1.4.5.1.2.2.1. Japan Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
4.1.4.5.1.2.3. Japan Cardiac AI Monitoring and Diagnostics Market (by Application)
4.1.4.5.1.2.4. Japan Cardiac AI Monitoring and Diagnostics Market (by End User)
4.1.4.5.2. China
4.1.4.5.2.1. Market Dynamics
4.1.4.5.2.2. Market Size and Forecast
4.1.4.5.2.2.1. China Cardiac AI Monitoring and Diagnostics Market (by Product)
4.1.4.5.2.2.2. China Cardiac AI Monitoring and Diagnostics Market (by Type)
4.1.4.5.2.2.2.1. China Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
4.1.4.5.2.2.3. China Cardiac AI Monitoring and Diagnostics Market (by Application)
4.1.4.5.2.2.4. China Cardiac AI Monitoring and Diagnostics Market (by End User)
4.1.4.5.3. India
4.1.4.5.3.1. Market Dynamics
4.1.4.5.3.2. Market Size and Forecast
4.1.4.5.3.2.1. India Cardiac AI Monitoring and Diagnostics Market (by Product)
4.1.4.5.3.2.2. India Cardiac AI Monitoring and Diagnostics Market (by Type)
4.1.4.5.3.2.2.1. India Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
4.1.4.5.3.2.3. India Cardiac AI Monitoring and Diagnostics Market (by Application)
4.1.4.5.3.2.4. India Cardiac AI Monitoring and Diagnostics Market (by End User)
4.1.4.5.4. Australia
4.1.4.5.4.1. Market Dynamics
4.1.4.5.4.2. Market Size and Forecast
4.1.4.5.4.2.1. Australia Cardiac AI Monitoring and Diagnostics Market (by Product)
4.1.4.5.4.2.2. Australia Cardiac AI Monitoring and Diagnostics Market (by Type)
4.1.4.5.4.2.2.1. Australia Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
4.1.4.5.4.2.3. Australia Cardiac AI Monitoring and Diagnostics Market (by Application)
4.1.4.5.4.2.4. Australia Cardiac AI Monitoring and Diagnostics Market (by End User)
4.1.4.5.5. South Korea
4.1.4.5.5.1. Market Dynamics
4.1.4.5.5.2. Market Size and Forecast
4.1.4.5.5.2.1. South Korea Cardiac AI Monitoring and Diagnostics Market (by Product)
4.1.4.5.5.2.2. South Korea Cardiac AI Monitoring and Diagnostics Market (by Type)
4.1.4.5.5.2.2.1. South Korea Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
4.1.4.5.5.2.3. South Korea Cardiac AI Monitoring and Diagnostics Market (by Application)
4.1.4.5.5.2.4. South Korea Cardiac AI Monitoring and Diagnostics Market (by End User)
4.1.4.5.6. Rest-of-Asia-Pacific
4.1.4.5.6.1. Market Size and Forecast
4.1.4.5.6.1.1. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product)
4.1.4.5.6.1.2. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type)
4.1.4.5.6.1.2.1. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
4.1.4.5.6.1.3. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application)
4.1.4.5.6.1.4. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User)
5. Markets - Competitive Benchmarking & Company Profiles
5.1. Cardiac AI Monitoring and Diagnostics Active Players Ecosystem
5.2. Key Strategies and Developments
5.2.1. Regulatory and Legal Activities
5.3. Company Profiles
5.3.1. Canon Inc.
5.3.1.1. Company Overview
5.3.1.2. Role of Canon Inc. in the Cardiac AI Monitoring and Diagnostics Market
